Hyoscyamine (Levsin, Levbid, etc) is going off the market
All hyoscyamine products are unapproved. They came on the market before FDA approval was required. The FDA hasn't taken any action against these products...yet. But several companies have voluntarily withdrawn their products.
This has put a squeeze on the few remaining companies, creating a drug shortage.
There are only a handful of hyoscyamine products currently marketed. But these are either not available through some wholesalers and/or the cost of these may be prohibitive for some patients.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote